Stay updated with the latest finerenone news, articles, and insights from trusted sources. Explore in-depth coverage and expert analysis on finerenone topics.
New Delhi, Nov 6 (PTI) Drug firm Bayer on Thursday said it has received approval for its innovative therapy Kerendia for the treatment of heart failure from the Indian regulatory authorities. The product (finerenone) is already approved for chronic kidney disease (CKD) associated with type 2 diabetes (T2D). "With the expansion of finerenone's indication, we are addressing types of heart failure that account for nearly half of all heart failure cases but have had limited proven treatment option ...Read More >
Stay updated with the latest None news, articles, and insights from trusted sources. Explore in-depth coverage and expert analysis on None topics.